Skip to main content
SpringerLink
Log in

Metabolism of cyclosporine by cytochromes P450 3A9 and 3A4

  • Published:
European Journal of Drug Metabolism and Pharmacokinetics Aims and scope Submit manuscript

Summary

The ability of P450 3A9 to transform cyclosporine was studied and compared to that of human P450 3A4. Purified P450 3A4 and P450 3A9 proteins were reconstituted in a system containing potassium phosphate buffer, lipids, NADPH-P450 reductase, and glutathione with NADPH added to initiate the reaction. Cyclosporine was added alone and with or without the inhibitors, ketoconazole or troleandomycin. High performance liquid chromatography with ultraviolet (HPLC/UV) techniques were used to analyze for cyclosporine metabolites. Both P450 3A4 and P450 3A9 transformed cyclosporine to three metabolites: AM1, AM9, and AM4n. P450 3A4 predominantly formed AM1 (63% of metabolites formed) while P450 3A9 formed AM4n (59% of metabolites formed). Ketoconazole (0.5 μM) completely inhibited P450 3A9 catalyzed formation of AM1 and AM9 and reduced AM4n formation to 28% of control. AM4n, AM1, and AM9 formation catalyzed by P450 3A4 was reduced to 50%, 30%, and 10% of control, respectively, by 0.5 μM ketoconazole. Troleandomycin (>10μM) inhibited the formation of AM4n by P450 3A4 and P450 3A9 to 60–70% of control, while the production of AM1 by P450 3A4 was increased to 120% of control and the production of AM1 by P450 3A9 was inhibited to 50% of control. Inhibition of P450 3A4 by troleandomycin (>10 μM) reduced the formation of AM9 to 40% of control, but only reduced P450 3A9 formation of AM9 to 80% of control. This study shows that rat P450 3A9 is capable of transforming cyclosporine to multiple metabolites similar to those generated by human P450 3A4.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Consensus Document. (1990): Hawk’s Cay Meeting on Therapeutic Drug Monitoring of cyclosporine. Transplant Proc., 22, 1357–1361.

    Google Scholar 

  2. Maurer G., Loosli H.R., Schreier E., Keller B. (1984): Disposition of cyclosporine in several animal species and man. I. Structural elucidation of its metabolites. Drug Metab. Dispos., 12, 120–127.

    PubMed  CAS  Google Scholar 

  3. Kronbach T., Fischer V., Meyer U.A. (1988): Cyclosporine metabolism in human liver: identification of a cytochrome P450 III gene family as the major cyclosporine-metabolizing enzyme explains interactions of cyclosporine with other drugs. Clin. Pharmacol. Ther., 43, 630–635.

    PubMed  CAS  Google Scholar 

  4. Combalbert J., Fabre I., Fabre G. et al. (1989): Metabolism of cyclosporine A. IV. Purification and identification of rifampicin-inducible human liver cytochrome P-450 (cyclosporine A oxidase) as a product of P-450 IIIA gene subfamily. Drug Metab. Dispos., 17, 197–207.

    PubMed  CAS  Google Scholar 

  5. Waxman D.J., Dannan G.A., Guengerich F.P. (1985): Regulation of rat hepatic cytochrome P-450: age-dependent expression, hormonal imprinting, and xenobiotic inducibility of sex-specific isozymes. Biochemistry, 24, 4409–4417.

    Article  PubMed  CAS  Google Scholar 

  6. Prueksaritanont T., Correia M.A., Rettie A.E., Swinney D.C., Thomas P.E., Benet L.Z. (1993): Cyclosporine metabolism by rat liver microsomes: evidence for involvement of enzyme(s) other than cytochromes P-450 3A. Drug Metab. Dispos., 21, 730–737.

    PubMed  CAS  Google Scholar 

  7. Wassef R., Cohen Z., Langer B. (1985): Pharmacokinetic profiles of cyclosporine in rats. Influence of route of administration and dosage. Transplantation, 40, 489–493.

    Article  PubMed  CAS  Google Scholar 

  8. Wang H., Strobel H.W. (1997): Regulation of P450 3A9 gene expression by estrogen and catalytic studies using cytochrome P450 3A9 expressed inEscherichia coli. Arch. Biochem. Biophys., 344, 365–372.

    Article  PubMed  CAS  Google Scholar 

  9. White I.N., Muller-Eberhand U. (1977): Decreased liver cytochrome P-450 in rats caused by norethindrone or ethynyloestradiol. Biochem. J., 166, 57–64.

    PubMed  CAS  Google Scholar 

  10. Pichard L., Fabre I., Fabre G. et al. (1990): Cyclosporine A drug interactions: screening for inducers and inhibitors of cytochrome P-450 (cyclosporin A oxidase) in primary cultures of human hepatocytes and in liver microsomes. Drug Metab. Dispos., 18, 595–606.

    PubMed  CAS  Google Scholar 

  11. Guengerich F.P. (1988): Oxidation of 17α-ethynyl estradiol by human liver cytochrome P-450. Mol. Pharmacol., 33, 500–508.

    PubMed  CAS  Google Scholar 

  12. Dignam J.D., Strobel H.W. (1977): NADPH-cytochrome P-450 reductase from rat liver: purification by affinity chromatography and characterization. Biochemistry, 16, 1116–1123.

    Article  PubMed  CAS  Google Scholar 

  13. Shimada T., Misono K.S., Guengerich F.P. (1986): Human liver microsomal cytochrome P-450 mephenytoin 4-hydroxylase, a prototype of genetic polymorphism in oxidative drug metabolism. Purification and characterization of two similar forms involved in the reaction. J. Biol. Chem., 261, 909–921.

    PubMed  CAS  Google Scholar 

  14. Henriesson S., Lindholm A., Aravoglou P. (1990): Cyclosporin metabolism in human liver microsomes and its inhibition by other drugs. Pharmacol. Toxicol., 66, 49–52.

    Article  Google Scholar 

  15. Vickers A.E., Fischer V., Conners S. et al. (1992): Cyclosporin A metabolism in human liver, kidney, and intestine slices: comparison to rat and dog slices and human cell lines. Drug Metab. Dispos., 20, 802–809.

    PubMed  CAS  Google Scholar 

  16. Omar G., Whiting P.H., Hawksworth G.M., Humphrey M.J., Burke M.D. (1997): Ketoconazole and fluconazole inhibition of the metabolism of cyclosporine A by human liver in vitro. Ther. Drug Monit., 19, 436–45.

    Article  PubMed  CAS  Google Scholar 

  17. Lampen A., Christians U., Bader A., Hackbarth I., Sewing K.F. (1996): Drug interactions and interindividual variability of cyclosporine metabolism in the small intestine. Pharmacology, 52, 159–168.

    Article  PubMed  CAS  Google Scholar 

  18. Gonzalez F.J., Song B.J., Hardwick J.P. (1986): Pregnenolone 16 alpha-carbonitrile-inducible P-450 gene family: gene conversion and differential regulation. Mol. Cell. Biol., 6, 2969–2976.

    PubMed  CAS  Google Scholar 

  19. Yamazoe Y., Shimada M., Murayama N., Kawano S., Kato R. (1986): The regulation by growth hormone of microsomal testosterone 6-beta hydroxylase in male rat liver. J. Biochem., 100, 1095–1097.

    PubMed  CAS  Google Scholar 

  20. Shimada M., Nagata K., Murayama N., Yamazoe Y., Kato R. (1989): Role of growth hormone in modulating the constitutive and phenobarbital-induced levels of two P-450 (6) beta (testosterone 6-beta hydroxylase) mRNAs in rat livers. J. Biochem., 106, 1030–1034.

    PubMed  CAS  Google Scholar 

  21. Ribeiro V., Lechner M.C. (1992): Cloning and characterization of a novel CYP3A1 allelic variant: analysis of CYP3A1 and CYP3A2 sex-hormone-dependent expression reveals that the CYP3A2 gene is regulated by testosterone. Arch. Biochem. Biophys., 293, 147–152.

    Article  PubMed  CAS  Google Scholar 

  22. Schenkman J.B., Greim H. (deds) Cytochrome P450: Hand book of Experimental Pharmacology. vol. 105. Berlin: Springer.

  23. Prueksaritanont T., Hoener B.A., Benet L.Z. (1992): Effects of low-density lipoprotein and ethinyl estradiol on cyclosporine metabolism in isolated rat liver perfusions. Drug Metab. Dispos., 20, 547–552.

    PubMed  CAS  Google Scholar 

  24. Kahan B.D., Welsh M., Schoenberg L. et al. (1996): Variable oral absorption of cyclosporine: a biopharmaceutical risk factor for chronic renal allograft rejection. Transplantation, 62, 599–606.

    Article  PubMed  CAS  Google Scholar 

  25. Seethalakshmi L., Flores C., Carboni A.A., Bala R., Diamond D.A., Menon M. (1990): Cyclosporine: its effects on testicular function and fertility in the prepubertal rat. J. Androl., 11, 17–24.

    PubMed  CAS  Google Scholar 

  26. Sikka S.C., Bhasin S., Coy D.C., Koyle M.A., Swerdloff R.S., Rajfer J. (1988): Effects of cyclosporine on the hypothalamic-pituitary-gonadal axis in the male rat: mechanism of action. Endocrinology, 123, 1069–1074.

    Article  PubMed  CAS  Google Scholar 

  27. Nieszporek T., Grzeszczak W., Kokot F., Zukowska-Szczechowska E., Kusmierski S., Szkodny A. (1989): Influence of type of immunosuppressive therapy on secretion of somatotropin and function of the pituitary-adrenal and pituitary-gonadal axis in patients with a kidney transplant. Nephron, 53, 65–69.

    Article  PubMed  CAS  Google Scholar 

  28. Ramirez G., Narvarte J., Bittle P.A., Ayers-Chastain C., Dean S.E. (1991): Cyclosporine-induced alterations in the hypothalamic hypophyseal gonadal axis in transplant patients. Nephron, 58, 27–32.

    Article  PubMed  CAS  Google Scholar 

  29. Esquifino A.I., Moreno M.L., Agrasal C., Villanua M.A. (1995): Effects of cyclosporine on ovarian function in sham-operated and pituitary-grafted young female rats. Proc. Soc. Exp. Biol. Med., 208, 397–403.

    PubMed  CAS  Google Scholar 

  30. Hirasawa K., Enosawa S. (1990): Effects of sex steroid hormones on sex-associated differences in the survival time of allogeneic skin grafts in rats. Transplantation, 50, 637–641.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Biochemistry and Molecular Biology, University of Texas-Houston Health Science Center, 6431 Fannin Street, Suite 6.240, 77030, Houston, TX, USA

    H. Wang & H. W. Strobel

  2. College of Pharmacy, University of Houston, Houston, Texas, USA

    P. A. Kelly

  3. Division of Immunology and Organ Transplantation, UT-Houston Medical School, 6431 Fannin Street, Suite 6.240, 77030, Houston, TX, USA

    P. A. Kelly, K. L. Napoli & B. D. Kahan

Authors
  1. P. A. Kelly
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. H. Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. K. L. Napoli
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. B. D. Kahan
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. H. W. Strobel
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kelly, P.A., Wang, H., Napoli, K.L. et al. Metabolism of cyclosporine by cytochromes P450 3A9 and 3A4. Eur. J. Drug Metab. Pharmacokinet. 24, 321–328 (1999). https://doi.org/10.1007/BF03190040

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03190040

Keywords

Search

Navigation